Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects

ConditionHealthy

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19+

SponsorDong-A ST Co., Ltd.

About this trial

This study is to compare pharmacokinetics and safety profiles of DA-5222 single-administration and co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in healthy adult subjects

Eligibility criteria

Qualifiers

Healthy volunteers

BMI between 18 and 30 kg/m2

Body weight: Male≥50kg, Female≥45kg

Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study

Disqualifiers

Subjects with clinically significant medical history

Subjects with history of drug abuse or addicted

Subjects with allergy or drug hypersensitivity

Trial design

Treatments tested in this trial

DA-5222
DA-5222-R1
DA-5222-R2
DA-5222-R3

Treatment groups

48 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Dong-A ST Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov